Page last updated: 2024-08-17

nadp and Parkinsonian Disorders

nadp has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guerra, MJ; Labandeira-Garcia, JL; Muñoz, A; Parga, JA; Rey, P; Rodriguez-Pallares, J	1

Other Studies

1 other study(ies) available for nadp and Parkinsonian Disorders

Article	Year
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiology of disease, 2008, Volume: 31, Issue:1 Topics: Adrenergic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Brain; Cells, Cultured; Dopamine; Fluorescent Antibody Technique; Immunohistochemistry; Microglia; NADP; Nerve Degeneration; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction	2008

Article

Year

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

Neurobiology of disease, 2008, Volume: 31, Issue:1

Topics: Adrenergic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Brain; Cells, Cultured; Dopamine; Fluorescent Antibody Technique; Immunohistochemistry; Microglia; NADP; Nerve Degeneration; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction

2008